Attentional load interferes with target localization across saccades

Peer reviewedPostprin

Driving forces in free visual search : An ethology

Peer reviewedPostprin

Russian blues reveal the limits of language influencing colour discrimination

Chromatic stimuli across a boundary of basic colour categories (BCCs; e.g. blue and green) are discriminated faster than colorimetrically equidistant colours within a given category. Russian has two BCCs for blue, sinij ‘dark blue’ and goluboj ‘light blue’. These language-specific BCCs were reported to enable native Russian speakers to discriminate cross-boundary dark and light blues faster than English speakers (Winawer et al., 2007, PNAS, 4, 7780–7785). We re-evaluated this finding in two experiments that employed identical tasks as in the cited study. In Experiment 1, Russian and English speakers categorised colours as sinij/goluboj or dark blue/light blue respectively; this was followed by a colour discrimination task. In Experiment 2, Russian speakers initially performed the discrimination task on sinij/goluboj and goluboj/zelënyj ‘green’ sets. They then categorised these colours in three frequency contexts with each stimulus presented: (i) an equal number of times (unbiased); more frequent (ii) either sinij or goluboj; (iii) either goluboj or zelënyj. We observed a boundary response speed advantage for goluboj/zelënyj but not for sinij/goluboj. The frequency bias affected only the sinij/goluboj boundary such that in a lighter context, the boundary shifted towards lighter shades, and vice versa. Contrary to previous research, our results show that in Russian, stimulus discrimination at the lightness-defined blue BCC boundary is not reflected in processing speed. The sinij/goluboj boundary did have a sharper categorical transition than the dark blue/light blue boundary, but it was also affected by frequency and order biases, demonstrating that “Russian blues” are less well-structured than previously thought

No advantage for separating overt and covert attention in visual search

Funding: This study was funded, in part, by an National Research University Higher School of Economics Lab grant for the Vision Modelling Lab (author MacInnes); grants #152427 and IRF #173947-052 from the Icelandic Research Fund; and the research fund of the University of Iceland (Author Kristjánsson). Publisher Copyright: © 2020 by the authors. Licensee MDPI, Basel, Switzerland.We move our eyes roughly three times every second while searching complex scenes, but covert attention helps to guide where we allocate those overt fixations. Covert attention may be allocated reflexively or voluntarily, and speeds the rate of information processing at the attended location. Reducing access to covert attention hinders performance, but it is not known to what degree the locus of covert attention is tied to the current gaze position. We compared visual search performance in a traditional gaze-contingent display, with a second task where a similarly sized contingent window is controlled with a mouse, allowing a covert aperture to be controlled independently by overt gaze. Larger apertures improved performance for both the mouse-and gaze-contingent trials, suggesting that covert attention was beneficial regardless of control type. We also found evidence that participants used the mouse-controlled aperture somewhat independently of gaze position, suggesting that participants attempted to untether their covert and overt attention when possible. This untethering manipulation, however, resulted in an overall cost to search performance, a result at odds with previous results in a change blindness paradigm. Untethering covert and overt attention may therefore have costs or benefits depending on the task demands in each case.Peer reviewe

Implicit processing during change blindness revealed with mouse-contingent and gaze-contingent displays

Publisher's version (útgefin grein)People often miss salient events that occur right in front of them. This phenomenon, known as change blindness, reveals the limits of visual awareness. Here, we investigate the role of implicit processing in change blindness using an approach that allows partial dissociation of covert and overt attention. Traditional gaze-contingent paradigms adapt the display in real time according to current gaze position. We compare such a paradigm with a newly designed mouse-contingent paradigm where the visual display changes according to the real-time location of a user-controlled mouse cursor, effectively allowing comparison of change detection with mainly overt attention (gaze-contingent display; Experiment 2) and untethered overt and covert attention (mouse-contingent display; Experiment 1). We investigate implicit indices of target detection during change blindness in eye movement and behavioral data, and test whether affective devaluation of unnoticed targets may contribute to change blindness. The results show that unnoticed targets are processed implicitly, but that the processing is shallower than if the target is consciously detected. Additionally, the partial untethering of covert attention with the mouse-contingent display changes the pattern of search and leads to faster detection of the changing target. Finally, although it remains possible that the deployment of covert attention is linked to implicit processing, the results fall short of establishing a direct connection.The studies reported in this article were supported by Russian Foundation for Basic Research (#15-06-09321А) and Icelandic Research Fund (IRF #152427)Peer Reviewe

A Generative Model of Cognitive State from Task and Eye Movements

The early eye tracking studies of Yarbus provided descriptive evidence that an observer’s task influences patterns of eye movements, leading to the tantalizing prospect that an observer’s intentions could be inferred from their saccade behavior. We investigate the predictive value of task and eye movement properties by creating a computational cognitive model of saccade selection based on instructed task and internal cognitive state using a Dynamic Bayesian Network (DBN). Understanding how humans generate saccades under different conditions and cognitive sets links recent work on salience models of low-level vision with higher level cognitive goals. This model provides a Bayesian, cognitive approach to top-down transitions in attentional set in pre-frontal areas along with vector-based saccade generation from the superior colliculus. Our approach is to begin with eye movement data that has previously been shown to differ across task. We first present an analysis of the extent to which individual saccadic features are diagnostic of an observer’s task. Second, we use those features to infer an underlying cognitive state that potentially differs from the instructed task. Finally, we demonstrate how changes of cognitive state over time can be incorporated into a generative model of eye movement vectors without resorting to an external decision homunculus. Internal cognitive state frees the model from the assumption that instructed task is the only factor influencing observers’ saccadic behavior. While the inclusion of hidden temporal state does not improve the classification accuracy of the model, it does allow accurate prediction of saccadic sequence results observed in search paradigms. Given the generative nature of this model, it is capable of saccadic simulation in real time. We demonstrated that the properties from its generated saccadic vectors closely match those of human observers given a particular task and cognitive state. Many current models of vision focus entirely on bottom-up salience to produce estimates of spatial “areas of interest” within a visual scene. While a few recent models do add top-down knowledge and task information, we believe our contribution is important in three key ways. First, we incorporate task as learned attentional sets that are capable of self-transition given only information available to the visual system. This matches influential theories of bias signals by (Miller and Cohen Annu Rev Neurosci 24:167–202, 2001) and implements selection of state without simply shifting the decision to an external homunculus. Second, our model is generative and capable of predicting sequence artifacts in saccade generation like those found in visual search. Third, our model generates relative saccadic vector information as opposed to absolute spatial coordinates. This matches more closely the internal saccadic representations as they are generated in the superior colliculus

Eye movement behavior in a real-world virtual reality task reveals ADHD in children

Peer reviewe

Breast cancer management pathways during the COVID-19 pandemic: outcomes from the UK ‘Alert Level 4’ phase of the B-MaP-C study

Abstract: Background: The B-MaP-C study aimed to determine alterations to breast cancer (BC) management during the peak transmission period of the UK COVID-19 pandemic and the potential impact of these treatment decisions. Methods: This was a national cohort study of patients with early BC undergoing multidisciplinary team (MDT)-guided treatment recommendations during the pandemic, designated ‘standard’ or ‘COVID-altered’, in the preoperative, operative and post-operative setting. Findings: Of 3776 patients (from 64 UK units) in the study, 2246 (59%) had ‘COVID-altered’ management. ‘Bridging’ endocrine therapy was used (n = 951) where theatre capacity was reduced. There was increasing access to COVID-19 low-risk theatres during the study period (59%). In line with national guidance, immediate breast reconstruction was avoided (n = 299). Where adjuvant chemotherapy was omitted (n = 81), the median benefit was only 3% (IQR 2–9%) using ‘NHS Predict’. There was the rapid adoption of new evidence-based hypofractionated radiotherapy (n = 781, from 46 units). Only 14 patients (1%) tested positive for SARS-CoV-2 during their treatment journey. Conclusions: The majority of ‘COVID-altered’ management decisions were largely in line with pre-COVID evidence-based guidelines, implying that breast cancer survival outcomes are unlikely to be negatively impacted by the pandemic. However, in this study, the potential impact of delays to BC presentation or diagnosis remains unknown

Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Dimethyl fumarate (DMF) inhibits inflammasome-mediated inflammation and has been proposed as a treatment for patients hospitalised with COVID-19. This randomised, controlled, open-label platform trial (Randomised Evaluation of COVID-19 Therapy [RECOVERY]), is assessing multiple treatments in patients hospitalised for COVID-19 (NCT04381936, ISRCTN50189673). In this assessment of DMF performed at 27 UK hospitals, adults were randomly allocated (1:1) to either usual standard of care alone or usual standard of care plus DMF. The primary outcome was clinical status on day 5 measured on a seven-point ordinal scale. Secondary outcomes were time to sustained improvement in clinical status, time to discharge, day 5 peripheral blood oxygenation, day 5 C-reactive protein, and improvement in day 10 clinical status. Between 2 March 2021 and 18 November 2021, 713 patients were enroled in the DMF evaluation, of whom 356 were randomly allocated to receive usual care plus DMF, and 357 to usual care alone. 95% of patients received corticosteroids as part of routine care. There was no evidence of a beneficial effect of DMF on clinical status at day 5 (common odds ratio of unfavourable outcome 1.12; 95% CI 0.86-1.47; p = 0.40). There was no significant effect of DMF on any secondary outcome

Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Dimethyl fumarate (DMF) inhibits inflammasome-mediated inflammation and has been proposed as a treatment for patients hospitalised with COVID-19. This randomised, controlled, open-label platform trial (Randomised Evaluation of COVID-19 Therapy [RECOVERY]), is assessing multiple treatments in patients hospitalised for COVID-19 (NCT04381936, ISRCTN50189673). In this assessment of DMF performed at 27 UK hospitals, adults were randomly allocated (1:1) to either usual standard of care alone or usual standard of care plus DMF. The primary outcome was clinical status on day 5 measured on a seven-point ordinal scale. Secondary outcomes were time to sustained improvement in clinical status, time to discharge, day 5 peripheral blood oxygenation, day 5 C-reactive protein, and improvement in day 10 clinical status. Between 2 March 2021 and 18 November 2021, 713 patients were enroled in the DMF evaluation, of whom 356 were randomly allocated to receive usual care plus DMF, and 357 to usual care alone. 95% of patients received corticosteroids as part of routine care. There was no evidence of a beneficial effect of DMF on clinical status at day 5 (common odds ratio of unfavourable outcome 1.12; 95% CI 0.86-1.47; p = 0.40). There was no significant effect of DMF on any secondary outcome